N-Nitroso Tadalafil
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Tadalafil is used to treat men who have erectile dysfunction (also called sexual impotence). Tadalafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. These medicines prevent an enzyme called phosphodiesterase type-5 from working too quickly.Tadalafil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Tadalafil or Tadalafil Nitroso Impurity 1 CAS NO:NA also known as N-Nitroso Tadalafil Impurity Chemically represented as (6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-nitroso-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione . Synchemia is the leading manufacturing and exporter of Tadalafil Nitroso Impurity 1 . We supply Tadalafil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141667 |
| CAS No | NA |
| Mol.F. | C10H9ClN2O2 |
| Mol.Wt. | 224.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141668 |
| CAS No | 2912492-21-6 |
| Mol.F. | C9H14N2O3 |
| Mol.Wt. | 198.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141669 |
| CAS No | NA |
| Mol.F. | C17H27N3O6 |
| Mol.Wt. | 369.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141670 |
| CAS No | NA |
| Mol.F. | C20H33N3O6 |
| Mol.Wt. | 411.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141671 |
| CAS No | NA |
| Mol.F. | C19H31N3O6 |
| Mol.Wt. | 397.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141672 |
| CAS No | NA |
| Mol.F. | C12H12F2N2O2 |
| Mol.Wt. | 254.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141673 |
| CAS No | NA |
| Mol.F. | C12H13F2N3O2 |
| Mol.Wt. | 269.3 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0141674 |
| CAS No | NA |
| Mol.F. | C15H21N3O |
| Mol.Wt. | 259.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141675 |
| CAS No | NA |
| Mol.F. | C19H25N3O3 |
| Mol.Wt. | 343.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141676 |
| CAS No | NA |
| Mol.F. | C15H15ClN4OS |
| Mol.Wt. | 334.82 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141677 |
| CAS No | NA |
| Mol.F. | C19H26N2O |
| Mol.Wt. | 298.4 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141678 |
| CAS No | NA |
| Mol.F. | C19H20N2O2 |
| Mol.Wt. | 308.4 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141679 |
| CAS No | NA |
| Mol.F. | C13H11N4OS.Cl |
| Mol.Wt. | 306.77 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141680 |
| CAS No | NA |
| Mol.F. | C15H15N4OS |
| Mol.Wt. | 299.4 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141681 |
| CAS No | NA |
| Mol.F. | C19H20N2O4 |
| Mol.Wt. | 340.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141682 |
| CAS No | NA |
| Mol.F. | C12H15FN2O2 |
| Mol.Wt. | 238.3 |
| INV STATUS | CUSTOM SYNTHESIS |